Long‐term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study-Reference-Cited by-同舟云学术

Long‐term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study

Published:2022-02-25 Issue:4 Volume:29 Page:289-296
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:Journal of Viral Hepatitis

Author:

Chon Young Eun¹,Park Soo Young²,Kim Seung Up³⁴⁵^ORCID,Hong Han Pyo⁶,Lee Jae Seung³⁴⁵^ORCID,Lee Hye Won³⁴⁵^ORCID,Kim Mi Na¹^ORCID,Park Jun Yong³⁴⁵,Kim Do Young³⁴⁵,Ahn Sang Hoon³⁴⁵,Kim Beom Kyung³⁴⁵^ORCID

Affiliation:

1. Department of Internal Medicine Cha Bundang Medical Center Cha University Seongnam Korea

2. Department of Internal Medicine School of Medicine Kyungpook National UniversityKyungpook National University Hospital Daegu Korea

3. Department of Internal Medicine Yonsei University College of Medicine Seoul Korea

4. Yonsei Liver Center Severance HospitalYonsei University Health System Seoul Korea

5. Institute of GastroenterologyYonsei University College of Medicine Seoul Korea

6. Big Data Center Department of Statistics Yonsei University Wonju College of Medicine Wonju‐si Korea

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13656

Reference35 articles.

1. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

2. Natural course following the onset of cirrhosis in patients with chronic hepatitis B: a long-term follow-up study

3. Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load

4. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

5. KASL clinical practice guidelines for management of chronic hepatitis B

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal dysfunction during treatment of chronic hepatitis B with tenofovir disoproxyl fumarate and associated risk factors;European Journal of Gastroenterology & Hepatology;2024-02-23

2. Longitudinal changes in renal function in patients with chronic hepatitis B on antiviral treatment;Alimentary Pharmacology & Therapeutics;2023-11-27

3. Renal Safety of Long-term Tenofovir Disoproxil Fumarate Treatment in Patients With Chronic Hepatitis B;Open Forum Infectious Diseases;2023-08-01

4. Synthesis of IR‐415 Derivatives and Evaluation of their Antiviral Activity Against Hepatitis B Virus;ChemistrySelect;2023-08

5. TACE versus TACE + entecavir versus TACE + tenofovir in the treatment of HBV associated hepatocellular carcinoma;BMC Cancer;2023-03-13